Register

scientific Sessions

  • Home
  • Scientific Sessions

Obesity and Type 2 Diabetes:

One of the most significant risk factors for type 2 diabetes is insulin signaling disrupted by excessive fat, particularly visceral adiposity, resulting in insulin resistance. Chronic inflammation, disturbed secretion of adipokines, and blunted glucose metabolism contribute significantly to the development of T2D. Management of obesity with weight loss, physical activity, and pharmacotherapy considerably reduces the risk of type 2 diabetes or delaying its onset. The International Obesity and Metabolism Conference-IOMC focuses on the integrative link between obesity and T2D, underscoring studies on prevention, early detection, and new therapeutic approaches regarding these two interconnected metabolic disorders.

Related Sessions

Obesity and genetic obesity
Diabetes and Obesity
Nutritional deficiencies in the obese
Genetics and Transplantation of Diabetes
Obesity and Cardiac issues
New Directions in Obesity Treatment
Omega 3 Fats An Essential Contribution
Diabetes and Obesity Treatment
Eating Disorders and Digestive Diseases
Diabetes, Metabolism, and Obesity
Diabetes and cholesterol
Cancer in Obesity
Molecular Mechanisms Underpinning Obesity
Emerging Frontiers in Adipose Tissue Biology
Advancements in Obesity Genetics
Childhood Obesity: Early Life Determinants and Interventions
Gut Microbiome as a Contributory Factor in Obesity
Nutritional Innovative Approaches to Obesity Management
Behavioral and Psychosocial Dimensions of Obesity
Pharmacotherapy of Obesity:
Obesity and Type 2 Diabetes:
Epigenetics and Metabolism in Obesity
Exercise as Medicine: Metabolic Benefits Beyond Weight Loss
Hormonal Imbalances in Obesity
Gender-Specific Challenges in Obesity Management
New Advances in Bariatric Surgery
New Advances in Bariatric Surgery
Social Determinants of Obesity
Obesity and Cardiovascular Risks
Innovations in the Management of Obesity
Obesity and Aging:
Don't miss our future updates!

Get in Touch